Phenotypic Characterization by Single-Cell Mass Cytometry of Human Intrahepatic and Peripheral NK Cells in Patients with Hepatocellular Carcinoma

Overall response rates of systemic therapies against advanced hepatocellular carcinoma (HCC) remain unsatisfactory. Thus, searching for new immunotherapy targets is indispensable. NK cells are crucial effectors and regulators in the tumor microenvironment and a determinant of responsiveness to checkpoint inhibitors. We revealed the landscape of NK cell phenotypes in HCC patients to find potential immunotherapy targets. Using single cell mass cytometry, we analyzed 32 surface markers on CD56dim and CD56bright NK cells, which included Sialic acid-binding immunoglobulin-type lectins (Siglecs). We compared peripheral NK cells between HCC patients and healthy volunteers. We also compared NK cells, in terms of their localizations, on an individual patient bases between peripheral and intrahepatic NK cells from cancerous and noncancerous liver tissues. In the HCC patient periphery, CD160+CD56dim NK cells that expressed Siglec-7, NKp46, and NKp30 were reduced, while CD49a+CD56dim NK cells that expressed Siglec-10 were increased. CD160 and CD49a on CD56dim NK cells were significantly correlated to other NK-related markers in HCC patients, which suggested that CD160 and CD49a were signature molecules. CD49a+ CX3CR1+ Siglec-10+ NK cells had accumulated in HCC tissues. Considering further functional analyses, CD160, CD49a, CX3CR1, and Siglec-10 on CD56dim NK cells may be targets for immunotherapies of HCC patients.

[1]  G. Missale,et al.  Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma , 2021, Cells.

[2]  T. Honda,et al.  Increased Frequency of Dysfunctional Siglec-7−CD57+PD-1+ Natural Killer Cells in Patients With Non-alcoholic Fatty Liver Disease , 2021, Frontiers in Immunology.

[3]  D. Durantel,et al.  Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion , 2021, eLife.

[4]  Chi-Ling Chen,et al.  Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods , 2020, BMC cancer.

[5]  Bixiang Zhang,et al.  Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1‐CX3CR1 dependent manner and induce tumour cell apoptosis , 2020, Molecular oncology.

[6]  Feng-Hou Gao,et al.  Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10 , 2020, Frontiers in Immunology.

[7]  D. Noonan,et al.  Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors , 2020, bioRxiv.

[8]  J. Li,et al.  Reduced Siglec‐7 expression on NK cells predicts NK cell dysfunction in primary hepatocellular carcinoma , 2020, Clinical and experimental immunology.

[9]  C. O’Farrelly,et al.  Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function , 2019, International journal of molecular sciences.

[10]  Rachel E. Brewer,et al.  CD24 signalling through macrophage Siglec-10 is a new target for cancer immunotherapy , 2019, Nature.

[11]  Meijuan Huang,et al.  Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma , 2019, Cancer Immunology Research.

[12]  C. Porta,et al.  Deficient Natural Killer Cell NKp30‐Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma , 2019, Hepatology.

[13]  Meijuan Huang,et al.  Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma , 2019, Hepatology.

[14]  Meijuan Huang,et al.  Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC. , 2018, Cancer research.

[15]  S. Asthana,et al.  A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments , 2018, Nature Medicine.

[16]  E. Sahai,et al.  NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control , 2018, Cell.

[17]  Abigail K Kimball,et al.  A Beginner’s Guide to Analyzing and Visualizing Mass Cytometry Data , 2018, The Journal of Immunology.

[18]  Y. Cheng,et al.  Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers , 2017, Oncogene.

[19]  Meijuan Huang,et al.  High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer , 2017, Oncoimmunology.

[20]  G. Bernardini,et al.  Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases , 2016, Front. Immunol..

[21]  G. Ferraioli,et al.  Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection , 2015, Gut.

[22]  Nicholas K. Brown,et al.  CD160 is essential for NK-mediated IFN-γ production , 2015, The Journal of experimental medicine.

[23]  K. Tao,et al.  Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. , 2015, The Journal of surgical research.

[24]  H. Ljunggren,et al.  Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+ NK Cells , 2015, The Journal of Immunology.

[25]  P. Romero,et al.  Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. , 2014, The Journal of clinical investigation.

[26]  M. Makuuchi,et al.  Prognostic Impact of Spontaneous Tumor Rupture in Patients With Hepatocellular Carcinoma: An Analysis of 1160 Cases From a Nationwide Survey , 2014, Annals of surgery.

[27]  W. Pan,et al.  Monocyte/macrophage‐elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions , 2013, Hepatology.

[28]  I. Ng,et al.  Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma , 2011, Gut.

[29]  A. Moretta,et al.  The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. , 2009, Blood.

[30]  M. Manns,et al.  Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor , 2009, Hepatology.

[31]  P. Tien,et al.  Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. , 2008, Clinical immunology.

[32]  M. Caligiuri,et al.  Human natural killer cell development , 2006, Immunological reviews.

[33]  Kazuyoshi Takeda,et al.  New aspects of natural-killer-cell surveillance and therapy of cancer , 2002, Nature Reviews Cancer.

[34]  G. Leca,et al.  A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity , 1993, The Journal of experimental medicine.

[35]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.